慢性骨髓性白血病治療的全球市場 2022-2026年

本報告慢性骨髓性白血病治療的市場規模在2022年～2026年間，預測將成長到21億4000萬美元，在預測期間內預計將以年複合成長率6.1％增長。

本報告提供慢性骨髓性白血病治療市場相關資料，整體分析，提供市場規模與預測，趨勢，成長促進因素，網羅了課題，再加上約25供應商的供應商分析。

同時本報告還提供當前全球市場趨勢與推動因素以及整體市場環境的最新分析。市場成長的主要因素有策略性聯盟。

目錄

第1章 摘要整理

• 市場概要

第2章 市場形勢

• 市場生態系統

第3章 市場規模

• 市場定義
• 市場區隔分析
• 市場規模 2021
• 市場預測:2021-2026年的預測

第4章 波特的五力分析

• 五力的摘要
• 買方議價能力
• 供給企業談判力
• 新加入廠商業者的威脅
• 替代品的威脅
• 競爭的威脅
• 市場情況

第5章 各產品的市場區隔

• 市場明細
• 各產品比較
• 標靶治療 - 市場規模與預測 2021-2026
• 化療 - 市場規模與預測 2021-2026
• 免疫療法 - 市場規模與預測 2021-2026
• 各產品的市場機會

第6章 客戶形勢

• 客戶形勢概要

第7章 各地區形勢

• 各地區市場區隔
• 各地區比較
• 北美 - 市場規模與預測 2021-2026
• 歐洲 - 市場規模與預測 2021-2026
• 亞洲 - 市場規模與預測 2021-2026
• 其他地區(ROW) - 市場規模與預測 2021-2026
• 美國 - 市場規模與預測 2021-2026
• 德國 - 市場規模與預測 2021-2026
• 英國 - 市場規模與預測 2021-2026
• 中國 - 市場規模與預測 2021-2026
• 加拿大 - 市場規模與預測 2021-2026
• 各地區形勢的市場機會

第8章 原動力，課題，及趨勢

• 推動市場要素
• 市場課題
• 推動要素與課題的影響
• 市場趨勢

第9章 業者情勢

• 概要
• 業者情勢
• 混亂狀況
• 產業的風險

第10章 供應商分析

• 交易廠商
• 供應商的市場定位
• Bristol Myers Squibb Co.
• C. H. Boehringer Sohn AG and Co. KG
• Merck KGaA
• Novartis AG
• Otsuka Holdings Co Ltd
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

第11章 附錄

Technavio has been monitoring the chronic myelogenous leukemia therapeutics market and it is poised to grow by $ 2.14 bn during 2022-2026, accelerating at a CAGR of 6.1% during the forecast period. Our report on the chronic myelogenous leukemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by strategic alliances.

The chronic myelogenous leukemia therapeutics market analysis includes the product segment and geographic landscape.

Technavio's chronic myelogenous leukemia therapeutics market is segmented as below:

By Product

• Targeted therapy
• Chemotherapy
• Immunotherapy

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the emergence of pipeline molecules as one of the prime reasons driving the chronic myelogenous leukemia therapeutics market growth during the next few years. Also, the development of diagnostic tests and predictive markers and increasing research in regenerative medicines will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the chronic myelogenous leukemia therapeutics market covers the following areas:

• Chronic myelogenous leukemia therapeutics market sizing
• Chronic myelogenous leukemia therapeutics market forecast
• Chronic myelogenous leukemia therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading chronic myelogenous leukemia therapeutics market vendors that include Amneal Pharmaceuticals Inc., Bristol Myers Squibb Co., C. H. Boehringer Sohn AG and Co. KG, Dr Reddys Laboratories Ltd, F. Hoffmann La Roche Ltd., Ilyang Pharmaceutical Co. Ltd., Innovent Biologics Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sheba Medical Center, Sun Pharmaceutical Industries Ltd, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Lupin Ltd, and Otsuka Holdings Co Ltd. Also, the chronic myelogenous leukemia therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

• 5.1 Market segments
• Exhibit 24: Chart on Product - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
• 5.2 Comparison by Product
• Exhibit 26: Chart on Comparison by Product
• Exhibit 27: Data Table on Comparison by Product
• 5.3 Targeted therapy - Market size and forecast 2021-2026
• Exhibit 28: Chart on Targeted therapy - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Targeted therapy - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Targeted therapy - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Targeted therapy - Year-over-year growth 2021-2026 (%)
• 5.4 Chemotherapy - Market size and forecast 2021-2026
• Exhibit 32: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
• 5.5 Immunotherapy - Market size and forecast 2021-2026
• Exhibit 36: Chart on Immunotherapy - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Immunotherapy - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Immunotherapy - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Immunotherapy - Year-over-year growth 2021-2026 (%)
• 5.6 Market opportunity by Product
• Exhibit 40: Market opportunity by Product ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 44: Chart on Geographic comparison
• Exhibit 45: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• 7.9 UK - Market size and forecast 2021-2026
• Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
• 7.10 China - Market size and forecast 2021-2026
• Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
• 7.11 Canada - Market size and forecast 2021-2026
• Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• 7.12 Market opportunity By Geographical Landscape
• Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 83: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 85: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 86: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 87: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 88: Matrix on vendor position and classification
• 10.3 Bristol Myers Squibb Co.
• Exhibit 89: Bristol Myers Squibb Co. - Overview
• Exhibit 90: Bristol Myers Squibb Co. - Product / Service
• Exhibit 91: Bristol Myers Squibb Co. - Key offerings
• 10.4 C. H. Boehringer Sohn AG and Co. KG
• Exhibit 92: C. H. Boehringer Sohn AG and Co. KG - Overview
• Exhibit 93: C. H. Boehringer Sohn AG and Co. KG - Business segments
• Exhibit 94: C. H. Boehringer Sohn AG and Co. KG - Key news
• Exhibit 95: C. H. Boehringer Sohn AG and Co. KG - Key offerings
• Exhibit 96: C. H. Boehringer Sohn AG and Co. KG - Segment focus
• 10.5 Merck KGaA
• Exhibit 97: Merck KGaA - Overview
• Exhibit 98: Merck KGaA - Business segments
• Exhibit 99: Merck KGaA - Key news
• Exhibit 100: Merck KGaA - Key offerings
• Exhibit 101: Merck KGaA - Segment focus
• 10.6 Novartis AG
• Exhibit 102: Novartis AG - Overview
• Exhibit 103: Novartis AG - Business segments
• Exhibit 104: Novartis AG - Key offerings
• Exhibit 105: Novartis AG - Segment focus
• 10.7 Otsuka Holdings Co Ltd
• Exhibit 106: Otsuka Holdings Co Ltd - Overview
• Exhibit 107: Otsuka Holdings Co Ltd - Business segments
• Exhibit 108: Otsuka Holdings Co Ltd - Key offerings
• Exhibit 109: Otsuka Holdings Co Ltd - Segment focus
• 10.8 Pfizer Inc.
• Exhibit 110: Pfizer Inc. - Overview
• Exhibit 111: Pfizer Inc. - Product / Service
• Exhibit 112: Pfizer Inc. - Key news
• Exhibit 113: Pfizer Inc. - Key offerings
• 10.9 Sun Pharmaceutical Industries Ltd
• Exhibit 114: Sun Pharmaceutical Industries Ltd - Overview
• Exhibit 115: Sun Pharmaceutical Industries Ltd - Product / Service
• Exhibit 116: Sun Pharmaceutical Industries Ltd - Key offerings
• 10.10 Takeda Pharmaceutical Co. Ltd.
• Exhibit 117: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 118: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 10.11 Teva Pharmaceutical Industries Ltd.
• Exhibit 121: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 122: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 123: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 124: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 125: Teva Pharmaceutical Industries Ltd. - Segment focus
• 10.12 Viatris Inc.
• Exhibit 126: Viatris Inc. - Overview
• Exhibit 127: Viatris Inc. - Business segments
• Exhibit 128: Viatris Inc. - Key offerings
• Exhibit 129: Viatris Inc. - Segment focus

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 130: Inclusions checklist
• Exhibit 131: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 132: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 133: Research methodology
• Exhibit 134: Validation techniques employed for market sizing
• Exhibit 135: Information sources
• 11.5 List of abbreviations
• Exhibit 136: List of abbreviations
  • health: Includes veterinary drugs (excluded from the scope of the report)

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Product
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between 2021 and 2026
• Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Product - Market share 2021-2026 (%)
• Exhibits25: Data Table on Product - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Product
• Exhibits27: Data Table on Comparison by Product
• Exhibits28: Chart on Targeted therapy - Market size and forecast 2021-2026 ($ million)
• Exhibits29: Data Table on Targeted therapy - Market size and forecast 2021-2026 ($ million)
• Exhibits30: Chart on Targeted therapy - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on Targeted therapy - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
• Exhibits33: Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
• Exhibits34: Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
• Exhibits36: Chart on Immunotherapy - Market size and forecast 2021-2026 ($ million)
• Exhibits37: Data Table on Immunotherapy - Market size and forecast 2021-2026 ($ million)
• Exhibits38: Chart on Immunotherapy - Year-over-year growth 2021-2026 (%)
• Exhibits39: Data Table on Immunotherapy - Year-over-year growth 2021-2026 (%)
• Exhibits40: Market opportunity by Product ($ million)
• Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits44: Chart on Geographic comparison
• Exhibits45: Data Table on Geographic comparison
• Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
• Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits82: Market opportunity By Geographical Landscape ($ million)
• Exhibits83: Impact of drivers and challenges in 2021 and 2026
• Exhibits84: Overview on Criticality of inputs and Factors of differentiation
• Exhibits85: Overview on factors of disruption
• Exhibits86: Impact of key risks on business
• Exhibits87: Vendors covered
• Exhibits88: Matrix on vendor position and classification
• Exhibits89: Bristol Myers Squibb Co. - Overview
• Exhibits90: Bristol Myers Squibb Co. - Product / Service
• Exhibits91: Bristol Myers Squibb Co. - Key offerings
• Exhibits92: C. H. Boehringer Sohn AG and Co. KG - Overview
• Exhibits93: C. H. Boehringer Sohn AG and Co. KG - Business segments
• Exhibits94: C. H. Boehringer Sohn AG and Co. KG - Key news
• Exhibits95: C. H. Boehringer Sohn AG and Co. KG - Key offerings
• Exhibits96: C. H. Boehringer Sohn AG and Co. KG - Segment focus
• Exhibits97: Merck KGaA - Overview
• Exhibits98: Merck KGaA - Business segments
• Exhibits99: Merck KGaA - Key news
• Exhibits100: Merck KGaA - Key offerings
• Exhibits101: Merck KGaA - Segment focus
• Exhibits102: Novartis AG - Overview
• Exhibits103: Novartis AG - Business segments
• Exhibits104: Novartis AG - Key offerings
• Exhibits105: Novartis AG - Segment focus
• Exhibits106: Otsuka Holdings Co Ltd - Overview
• Exhibits107: Otsuka Holdings Co Ltd - Business segments
• Exhibits108: Otsuka Holdings Co Ltd - Key offerings
• Exhibits109: Otsuka Holdings Co Ltd - Segment focus
• Exhibits110: Pfizer Inc. - Overview
• Exhibits111: Pfizer Inc. - Product / Service
• Exhibits112: Pfizer Inc. - Key news
• Exhibits113: Pfizer Inc. - Key offerings
• Exhibits114: Sun Pharmaceutical Industries Ltd - Overview
• Exhibits115: Sun Pharmaceutical Industries Ltd - Product / Service
• Exhibits116: Sun Pharmaceutical Industries Ltd - Key offerings
• Exhibits117: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibits118: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibits119: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibits120: Takeda Pharmaceutical Co. Ltd. - Key offerings
• Exhibits121: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits122: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits123: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits124: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits125: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits126: Viatris Inc. - Overview
• Exhibits127: Viatris Inc. - Business segments
• Exhibits128: Viatris Inc. - Key offerings
• Exhibits129: Viatris Inc. - Segment focus
• Exhibits130: Inclusions checklist
• Exhibits131: Exclusions checklist
• Exhibits132: Currency conversion rates for US$
• Exhibits133: Research methodology
• Exhibits134: Validation techniques employed for market sizing
• Exhibits135: Information sources
• Exhibits136: List of abbreviations